51³Ô¹ÏÍø

Tag - gilead

 
Menu
Search
 
July 25, 2026
 

Home Delivery
Subscribe for more access

GILEAD

Jared Baeten, Gilead Sciences' senior vice president and virology therapeutic area head, hopes regulatory approval elsewhere for lenacapavir as a preexposure prophylaxis ¡ª for reducing the risk of contracting HIV ¡ª could lead to real discussions toward ending HIV in Japan.
BUSINESS / Companies
Sep 22, 2025
Twice-a-year injection could make HIV prevention easier, developer argues
Without the need to take a daily pill, adherence could improve, says an executive from Gilead Sciences, which developed such an injection.
Foster City, California¡¯s Gilead is laser-focused on HIV and is seeking an actual cure.
BUSINESS / Companies
Mar 6, 2025
Gilead¡¯s Japan head says nation can be among first to end HIV epidemic
The pharmaceutical powerhouse has drugs that disrupt the transmission of the virus, one of which has been approved for prevention in Japan.
Electric candles at a memorial service for those who died from AIDS on the sidelines of the Japanese Society for AIDS Research conference on Thursday
51³Ô¹ÏÍø / Science & Health
Nov 29, 2024
Ahead of World AIDS Day, advocates call for an end to HIV stigma in Japan
While cases are relatively low in Japan, experts and stakeholders say the stigma often attached to patients needs to be addressed.
Community leaders discuss the role of pre-exposure prophylaxis (PrEP) in ending the HIV/AIDS threat to public health by 2030 at a seminar hosted by Gilead Sciences in Tokyo on Sept. 25.
51³Ô¹ÏÍø / Science & Health
Oct 1, 2024
HIV prevention drug remains out of reach for many in Japan despite approval
The drug¡¯s high cost together with insufficient knowledge and awareness are hindering efforts to broaden access to it, experts and community leaders say.
Japan Times
WORLD / Science & Health
Nov 20, 2020
WHO advises doctors not to use Gilead¡¯s remdesivir for COVID-19
The recommendation is a blow to Gilead¡¯s drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
Japan Times
BUSINESS / Companies
Jun 23, 2020
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
Japan Times
WORLD / Science & Health
May 23, 2020
Gilead¡¯s remdesivir mainly helped healthier COVID-19 patients
Gilead Sciences Inc.¡¯s remdesivir, the first medicine cleared for the treatment of COVID-19, mainly benefited healthier patients who weren¡¯t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market.
Japan Times
WORLD / Science & Health
May 2, 2020
U.S. emergency approval broadens use of Gilead¡¯s COVID-19 drug remdesivir
Gilead Science Inc.¡¯s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.
Japan Times
WORLD / Science & Health
May 1, 2020
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O¡¯Day said. How much revenue ¡ª if any ¡ª the company expects to generate is another matter.
Japan Times
WORLD / Science & Health
Apr 11, 2020
Two-thirds of severe COVID-19 cases improved with remdesivir drug
Gilead Sciences Inc.¡¯s experimental drug for patients with severe COVID-19 infections showed promise in an early analysis, raising tentative hope that the first treatment for the novel virus may be on the horizon.
BUSINESS
Feb 26, 2020
U.S. begins first coronavirus clinical trial testing Gilead¡¯s experimental drug
U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.¡¯s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
Japan Times
ASIA PACIFIC / Science & Health
Feb 14, 2020
Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials
An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East respiratory syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found.
Japan Times
ASIA PACIFIC / Science & Health
Feb 1, 2020
Coronavirus case in U.S. treated with Gilead drug may spur wider tests
The first reported use of an experimental Gilead Sciences Inc. drug to fight the novel coronavirus has encouraged doctors to support further testing of the medication.
Japan weighs regulating Pokemon cards amid trading mania
A Pokemon event is held in Jakarta on July 11
Head of Swiss euthanasia firm dies after collapsing while ascending Mount Fuji
Around 200,000 people typically scale the 3,776 meter Mount Fuji each year.
Indian brothers make manga debut in Japan
Two Indian brothers made their manga debut in Japan with "Kung Fu Kung Fool" ¡ª an action-comedy series that follows the adventures of a notorious thief and a young boy.
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
A team of researchers said they found a ¡°seed¡± that accelerates the amyloid beta accumulation process in the brain, naming it ¡°Peak 1 amyloid beta,¡± as seen in a mouse's brain.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
The sci-fi sensibilities of electronic trio Black Boboi
Black Boboi was formed in 2018 when solo artists Julia Shortreed, Utena Kobayashi and Ermhoi came together under Kobayashi¡¯s newly founded label, Bindividual.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Wes-P has millions of followers and his viral clips made him recognizable out of Japan.
The 180-day locals: Life on Japan¡¯s digital nomad visa
Christopher Flinn works remotely from Tokyo earlier this month. Japan issued 646 digital nomad visas in 2025, but tourism officials are hoping to increase that figure in the coming years, with Japan's relatively cheap cost of living and the weak yen seen as potential draws for young professionals.
Japan reveals hint of new defense spending target in fiscal blueprint
The Self-Defense Forces' Type 16 mobile combat vehicle fires during a joint live-fire drill with U.S. Marines as part of the annual Resolute Dragon exercises in Yufu, Oita Prefecture, on June 28.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo¡¯s Shinjuku Ward.
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By Alex K.T. Martin

SUSTAINABLE 51³Ô¹ÏÍø

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER